Department of Neurology, Center for Neuromuscular Diseases (Associated National Center in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic.
Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Eur J Pain. 2022 Feb;26(2):370-389. doi: 10.1002/ejp.1865. Epub 2021 Oct 10.
Despite the high prevalence of depression and anxiety in chronic pain conditions, current knowledge concerning emotional distress among painful diabetic polyneuropathy (pDSPN) and other diabetes mellitus (DM) sufferers is limited.
This observational multicentre cohort study employed the Hospital Anxiety and Depression Scale, the Beck Depression Inventory II and the State-Trait Anxiety Inventory to assess symptoms of depression and anxiety in several groups with diabetes, as well as in a control group. The study cohort included 347 pDSPN patients aged 63.4 years (median), 55.9% males; 311 pain-free diabetic polyneuropathy (nDSPN) patients aged 63.7 years, 57.9% males; 50 diabetes mellitus (DM) patients without polyneuropathy aged 61.5 years, 44.0% males; and 71 healthy controls (HC) aged 63.0 years, 42.3% males. The roles played in emotional distress were explored in terms of the biological, the clinical (diabetes-, neuropathy- and pain-related), the socio-economic and the cognitive factors (catastrophizing).
The study disclosed a significantly higher prevalence of the symptoms of depression and anxiety not only in pDSPN (46.7% and 60.7%, respectively), but also in patients with nDSPN (24.4% and 44.4%) and DM without polyneuropathy (22.0% and 30.0%) compared with HCs (7.0% and 14.1%, p < 0.001). Multiple regression analysis demonstrated the severity of pain and neuropathy, catastrophic thinking, type 2 DM, lower age and female sex as independent contributors to depression and anxiety.
In addition to the severity of neuropathic pain and its cognitive processing, the severity of diabetic polyneuropathy and demographic factors are key independent contributors to emotional distress in diabetic individuals.
In large cohorts of well-defined painless and painful diabetic polyneuropathy patients and diabetic subjects without polyneuropathy, we found a high prevalence of the symptoms of depression and anxiety, mainly in painful individuals. We have confirmed neuropathic pain, its severity and cognitive processing (pain catastrophizing) as dominant risk factors for depression and anxiety. Furthermore, some demographic factors (lower age, female sex), type 2 diabetes mellitus and severity of diabetic polyneuropathy were newly identified as important contributors to emotional distress independent of pain.
尽管慢性疼痛病症中抑郁和焦虑的发病率很高,但目前对于痛性糖尿病多发性神经病(pDSPN)和其他糖尿病患者的情绪困扰知之甚少。
本观察性多中心队列研究采用医院焦虑抑郁量表、贝克抑郁量表第二版和状态特质焦虑量表评估了几组糖尿病患者以及对照组的抑郁和焦虑症状。研究队列包括 347 名 63.4 岁(中位数)、男性占 55.9%的痛性糖尿病多发性神经病患者;311 名无痛性糖尿病多发性神经病(nDSPN)患者,年龄 63.7 岁,男性占 57.9%;50 名无多发性神经病的糖尿病患者,年龄 61.5 岁,男性占 44.0%;以及 71 名健康对照组(HC),年龄 63.0 岁,男性占 42.3%。从生物学、临床(糖尿病、神经病变和疼痛相关)、社会经济和认知因素(灾难化)方面探讨了情绪困扰的作用。
研究发现,不仅 pDSPN 患者(分别为 46.7%和 60.7%),而且 nDSPN 患者(分别为 24.4%和 44.4%)和无多发性神经病的糖尿病患者(分别为 22.0%和 30.0%)的抑郁和焦虑症状的发生率均显著高于 HC(分别为 7.0%和 14.1%,p<0.001)。多元回归分析表明,疼痛和神经病变的严重程度、灾难化思维、2 型糖尿病、年龄较小和女性是抑郁和焦虑的独立影响因素。
除了神经病理性疼痛的严重程度及其认知处理外,糖尿病多发性神经病的严重程度和人口统计学因素也是糖尿病患者情绪困扰的关键独立影响因素。
在明确诊断的无痛和痛性糖尿病多发性神经病患者以及无多发性神经病的糖尿病患者的大样本队列中,我们发现抑郁和焦虑症状的发生率较高,主要发生在痛性患者中。我们已经证实,神经病理性疼痛、其严重程度和认知处理(疼痛灾难化)是抑郁和焦虑的主要危险因素。此外,一些人口统计学因素(年龄较小、女性)、2 型糖尿病和糖尿病多发性神经病的严重程度被确定为与疼痛无关的情绪困扰的重要独立影响因素。